Results 141 to 150 of about 1,811 (225)

Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment. [PDF]

open access: yesACS Med Chem Lett
Xiao K   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy